|Mr. Philippe Deschamps||Chairman, CEO & Pres||673.44k||N/A||1962|
|Ms. Joyce N. LaViscount||CFO & COO||489.39k||N/A||1962|
|Dr. Jonathan Mark Sackier||Chief Medical Officer||N/A||N/A||1958|
|Dr. Brian W. Bapty Ph.D.||VP of Strategy and Bus. Devel.||N/A||N/A||1969|
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.
Helius Medical Technologies, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 7. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 6; Compensation: 7.